Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q45027701)
Watch
English
A coxib a day won't keep the doctor away
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
15325809
retrieved
8 December 2017
title
A coxib a day won't keep the doctor away
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15325809
retrieved
8 December 2017
author
Eric J. Topol
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15325809
retrieved
8 December 2017
Gary W. Falk
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15325809
retrieved
8 December 2017
language of work or name
English
0 references
publication date
1 August 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15325809
retrieved
8 December 2017
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed ID
15325809
retrieved
8 December 2017
volume
364
1 reference
stated in
Europe PubMed Central
PubMed ID
15325809
retrieved
8 December 2017
issue
9435
1 reference
stated in
Europe PubMed Central
PubMed ID
15325809
retrieved
8 December 2017
page(s)
639-640
1 reference
stated in
Europe PubMed Central
PubMed ID
15325809
retrieved
8 December 2017
cites work
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of cardiovascular events associated with selective COX-2 inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nonsteroidal anti-Inflammatory drugs and cardiovascular risk
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
COX-2 and beyond: Approaches to prostaglandin inhibition in human disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic arthritis research and gastrointestinal event trial of lumiracoxib - study design and patient demographics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclooxygenase-2 expression and inhibition in atherothrombosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selective COX-2 inhibition improves endothelial function in coronary artery disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(04)16906-7
1 reference
stated in
Europe PubMed Central
PubMed ID
15325809
retrieved
8 December 2017
PubMed ID
15325809
1 reference
stated in
Europe PubMed Central
PubMed ID
15325809
retrieved
8 December 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
